Published in Blood on August 01, 2007
The haematopoietic stem cell niche at a glance. J Cell Sci (2011) 1.63
Hematopoietic stem cell transplantation without irradiation. Nat Methods (2009) 1.27
Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy (2012) 0.98
CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis. Am J Pathol (2010) 0.95
A familiar stranger: CD34 expression and putative functions in SVF cells of adipose tissue. World J Stem Cells (2013) 0.88
Stem cells, inflammation and allergy. Allergy Asthma Clin Immunol (2009) 0.88
PTP1B deficiency exacerbates inflammation and accelerates leukocyte trafficking in vivo. J Immunol (2011) 0.85
In situ hematopoiesis: a regulator of TH2 cytokine-mediated immunity and inflammation at mucosal surfaces. Mucosal Immunol (2015) 0.75
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci (2011) 4.21
The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell (2009) 3.08
Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep (2012) 2.83
Hematopoietic stem cells do not engraft with absolute efficiencies. Blood (2005) 2.81
Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity (2012) 2.34
Novel functions of the CD34 family. J Cell Sci (2008) 2.18
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res (2004) 1.90
Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta (2009) 1.75
The role of podocalyxin in health and disease. J Am Soc Nephrol (2009) 1.66
ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma. PLoS Biol (2011) 1.53
Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood (2005) 1.41
The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One (2007) 1.25
CD34 facilitates the development of allergic asthma. Blood (2007) 1.25
CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity (2005) 1.22
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res (2013) 1.18
CD34 is a specific marker of mature murine mast cells. Exp Hematol (2002) 1.16
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One (2008) 1.14
The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma. Clin Exp Metastasis (2012) 1.13
CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation (2009) 1.11
Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol (2005) 1.06
Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes (2013) 1.05
Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. J Immunol (2009) 1.03
SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog (2013) 1.02
Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol (2009) 1.01
SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo. J Immunol (2009) 0.97
The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma. Am J Respir Crit Care Med (2010) 0.96
CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis. Am J Pathol (2010) 0.95
Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling. Gastroenterology (2010) 0.94
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis. Exp Hematol (2010) 0.94
CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration. Stem Cells (2011) 0.92
Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes. J Biol Chem (2011) 0.90
CD34 expression by mast cells: of mice and men. Blood (2005) 0.89
A familiar stranger: CD34 expression and putative functions in SVF cells of adipose tissue. World J Stem Cells (2013) 0.88
Stem cells, inflammation and allergy. Allergy Asthma Clin Immunol (2009) 0.88
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS One (2010) 0.87
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation. J Clin Invest (2014) 0.86
SHIP represses Th2 skewing by inhibiting IL-4 production from basophils. J Immunol (2010) 0.86
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration. PLoS One (2011) 0.86
CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Am J Respir Crit Care Med (2011) 0.86
Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer. Gynecol Oncol (2010) 0.84
Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene. Cancer Immunol Immunother (2009) 0.84
Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins. Stem Cells (2006) 0.82
Requirement for core 2 O-glycans for optimal resistance to helminth infection. PLoS One (2013) 0.81
Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery. Exp Hematol (2008) 0.80
Avian models to study the transcriptional control of hematopoietic lineage commitment and to identify lineage-specific genes. Cells Tissues Organs (2002) 0.79
The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm. Am J Respir Cell Mol Biol (2015) 0.79
CD34 mediates intestinal inflammation in Salmonella-infected mice. Cell Microbiol (2010) 0.79
Prion protein expression and release by mast cells after activation. J Infect Dis (2009) 0.78
Mouse models to evaluate the function of genes associated with allergic airway disease. Curr Opin Allergy Clin Immunol (2012) 0.78
Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens. Exp Hematol (2011) 0.78
Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele. PLoS One (2013) 0.76
Mast cells in human health and disease. Methods Mol Biol (2015) 0.76
The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation. Oncogene (2002) 0.76
Correction: CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. PLoS One (2016) 0.75
Preface. Mast cells. Methods Mol Biol (2015) 0.75
The changing landscape of human-animal chimera research: A Canadian regulatory perspective. Stem Cell Res (2009) 0.75
Mutant mice and animal models of airway allergic disease. Methods Mol Biol (2014) 0.75
Measurement of mast cell surface molecules by high-throughput immunophenotyping using transcription (HIT). Methods Mol Biol (2015) 0.75